Mail

UK markets closed

FTSE 100
8,237.72
-34.74(-0.42%)
FTSE 250
20,442.35
-56.37(-0.27%)
AIM
772.57
+0.19(+0.02%)
GBP/EUR
1.1822
+0.0000(+0.00%)
GBP/USD
1.2650
-0.0010(-0.08%)
Bitcoin GBP
50,857.51
+103.32(+0.20%)

Homes with impressive sports facilities

Properties with tennis and basketball courts to pools and even a football pitch at the doorstep

Cytori Cell Research Institute, Inc. (3750.T)

Tokyo - Tokyo Delayed price. Currency in JPY

Add to watchlist

965.00

-9.00

(-0.92%)

At close: 03:15PM JST

Currency in JPY

Valuation measures⁴

Market cap (intra-day)	8.62B
Enterprise value	15.66B
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	4.52
Price/book (mrq)	4.10
Enterprise value/revenue	8.22
Enterprise value/EBITDA	-25.02

Trading information

Stock price history

Beta (5Y monthly)	0.55
52-week change ³	-5.30%
S&P500 52-week change ³	26.24%
52-week high ³	1,284.00
52-week low ³	881.00
50-day moving average ³	976.60
200-day moving average ³	1,069.48

Share statistics

Avg vol (3-month) ³	13.83k
Avg vol (10-day) ³	1.94k
Shares outstanding ⁵	8.93M
Implied shares outstanding ⁶	8.95M
Float ⁸	3.49M
% held by insiders ¹	67.80%
% held by institutions ¹	6.95%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	30 Mar 2020
Last split factor ²	5:1
Last split date ³	29 Jan 2018

Financial highlights

Fiscal year

Fiscal year ends	31 Mar 2024
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	8.85%
Operating margin (ttm)	-186.58%

Management effectiveness

Return on assets (ttm)	-4.85%
Return on equity (ttm)	5.06%

Income statement

Revenue (ttm)	1.56B
Revenue per share (ttm)	174.72
Quarterly revenue growth (yoy)	-69.80%
Gross profit (ttm)	N/A
EBITDA	-520M
Net income avi to common (ttm)	138M
Diluted EPS (ttm)	-99.68
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	1.04B
Total cash per share (mrq)	116.26
Total debt (mrq)	2.47B
Total debt/equity (mrq)	88.44%
Current ratio (mrq)	2.66
Book value per share (mrq)	312.49

Cash flow statement

Operating cash flow (ttm)	-1.15B
Levered free cash flow (ttm)	-326.75M